Inozyme Pharma Inc.

INZY | NASDAQ

Price Alert Chart Builder DCF Calculator

$4

$0 (0.00%)

At close: Jul 01, 2025, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $258.25M

Enterprise Value $220.43M

Beta 2.29

Average Volume N/A

Shares Outstanding (Diluted) 64.28M

Shares Change YoY 4.06%

Institutional Ownership 78.66%

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 0.3%

1Y CAGR (ann.) -10.3%

5Y CAGR (ann.) N/A

All-Time CAGR -25.9%

Valuation

PE Ratio -2.35

Forward PE N/A

PEG Ratio 0.12

Forward PEG 0.08

PS Ratio N/A

Forward PS 7.20

PB Ratio 8.12

P/FCF Ratio -2.67

P/Adj. FCF Ratio -2.47

P/OCF Ratio -2.74

EV/Sales N/A

EV/EBIT -2.18

EV/EBITDA -2.20

EV/FCF -2.28

Earnings Yield -42.5%

FCF Yield -37.4%

Adj. FCF Yield -40.5%

Financial Health

Net Cash $38.49M

Total Debt $46.95M

Cash & Short-Term Investments $84.78M

Total Assets $95.16M

Current Ratio 3.56

Quick Ratio 3.56

Debt / Equity Ratio 0.81

Debt / EBITDA -0.47

Debt / FCF -0.49

OCF / Debt -2.06

Interest Coverage 18.72

Altman Z-Score -6.09

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -8.4%

Returns

Return on Assets -82.8%

Return on Equity -102.9%

Return on Invested Capital -99.4%

Return on Capital Employed -116.5%

Return on Tangible Assets -82.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -4.2%

EPS CAGR 5Y 19.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y -22.0%

FCF CAGR 5Y -20.5%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y 30.8%

Revenue Growth Next 3Y N/A

Earnings Date Aug 4, 2025

EPS Estimate (next Q) -$0.36

EPS Growth Est (next Q) -18.2%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $12

Price Target Upside 200.0%

Cash Flow

Operating Cash Flow $-96.52M

Free Cash Flow $-96.55M

Adj. Free Cash Flow $-104.66M

FCF Per Share -$1.46

OCF Per Share -$1.46

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-107.38M

EBITDA $-100.34M

Net Income $-106.72M

EPS (Diluted) -$1.70

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A